Pegylated Interferon Alfa-2b in Reducing Relapse Rates After Nucleos(t)ide Analogue Withdrawal in HBeAg-negative CHB Patients with Low Level HBsAg
NCT06900166
·
clinicaltrials.gov ↗
PHASE4
Phase
NOT_YET_RECRUITING
Status
360
Enrollment
OTHER
Sponsor class
Conditions
Chronic Hepatitis B
Interventions
DRUG:
PegIFN alfa-2b
DRUG:
PegIFN alfa-2b and NUC
Sponsor
Huashan Hospital